The cannabis movement and research surrounding the plant now have more momentum than at any other point since prohibition began.

The momentum for cannabis reform efforts and also for innovation in cannabis technology, medicine, and science is carrying the industry forward at a rapid pace.

First discovered in the 1960s, Cannabigerol (CBG), a once rare, non-psychoactive molecule from which hundreds of other cannabinoids are derived, recently gained momentum as more companies and brands like Avicanna Inc. AVCNF 0.55% learn of the molecule’s therapeutic benefits in over-the-counter and pharmaceutical applications.

According to recent investigations by Avicanna, CBG has similar properties to CBD, acting as a competitive partial agonist for cannabinoid receptors in the nervous system and immune cells.

According to new data, the week ending March 20, 2020 saw a nearly 67% decrease in merger and acquisition activity versus the same period in 2019.

In 2019, there were over 290 merger and acquisition transactions in the cannabis industry. We’re now over 3 months into 2020 and there have been just 20 so far, leading many investors to questions whether or not the novel coronavirus has killed the marijuana industry’s M&A streak.

Aggressive health measures to stem the spread of the Coronavirus or COVID-19 are changing everything, including the operation of CBD businesses.  And if there’s one thing CBD business owners are accustomed to, it’s change.

If you think oil and gas stocks have had a rough go of things in recent weeks, take a gander at marijuana stocks since March 31, 2019. Over the past year and change, most cannabis stocks have lost at least half of their value, with the losses being especially noticeable for Canadian pot stocks.

Aurora Cannabis, the most popular stock on millennial-focused online investing app Robinhood, is down approximately 91% since hitting its 2019 closing high in mid-March 2019. Meanwhile, Quebec-based HEXO (NYSE:HEXO) has retraced its steps 93% since it hit its closing high in April 2019.

The coronavirus has caused quite a big stir amongst marijuana stocks. In only a few short weeks, we have watched billions in market value go down the drain. During that time, however, we have also seen demand for cannabis shoot up. This could be attributed to the large portion of individuals staying at home with nothing to do, but it undoubtedly is a good sign. It appears as though the current losses are helping to show that there may be value in some beaten-down pot stocks. This means that we could see more bulls begin to enter the cannabis industry within the next few weeks.

CBD studies have demonstrated positive evidence when it comes to treating and preventing a range of illnesses, including degenerative diseases, cancer and metabolic disorders. But what about preventing heart disease and promoting heart health?

So you’re new to cannabis — welcome! You’ve likely already started enjoying and experimenting (always in moderation). The edibles at your local shop look so yummy, don’t they? But $15 for a brownie?! You’ve been baking your entire life. How tough can it be to make your own?

The answer: It’s not. But it’s likely not the same kind of baking you’re used to. To cook with marijuana properly (meaning effectively, as in, the marijuana doesn’t take over the flavor of the dish completely and it’s the correct dosage), you need to take the step even the most enthusiast “baker” down the street is probably forgetting — decarboxylation.

The cannabis companies that survive 2020 will be hardened, battled tested and able to thrive for years to come.

But make no mistake, the pandemic-related market collapse is shortening the runway for debt-riddled weed firms and the number of bankruptcies will start increasing in the coming months.

That’s according to Ranjeev Dhillon, partner at McCarthy Tetrault and co-leader of their cannabis division, who handles mergers, acquisitions and bankruptcies for some Canada’s largest weed companies.

The cannabis industry is in mourning the death of Charlotte Figi.

The 13-year-old was born in Colorado Spring, Colorado. From a young age, Charlotte became an inspiring face of hope for cannabis treatment due to her diagnosis of Dravet Syndrome, which is a rare and severe form of intractable epilepsy. She grew to be one of the world's most forefront advocates for the advancement of CBD and cannabis medical treatment in her lifetime.